Basic Information
| LncRNA/CircRNA Name | LINC00210 |
| Synonyms | NA |
| Region | GRCh38_1:217892900-217920804 |
| Ensemble | ENSG00000231814 |
| Refseq | NR_048550 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | non small cell lung cancer |
| ICD-0-3 | C34 |
| Methods | Luciferase reporter assay etc |
| Sample | NSCLC tissues, cell lines (SK-MES-1 and A549) |
| Expression Pattern | up-regulated |
| Function Description | The results demonstrated that LINC00210 was upregulated in NSCLC tissues and cell lines compared with that in normal tissues and 16-HBE cells, and that LINC00210 expression was associated with a poor prognosis in patients with NSCLC (P<0.05). Furthermore, A549 cell transfection with small interfering (si)LINC00210 and siLINC00210 induced a significant decrease in cell proliferation, and migratory and invasive abilities compared with that in the control groups (P<0.05). |
| Pubmed ID | 32266029 |
| Year | 2020 |
| Title | LINC00210 plays oncogenic roles in non-small cell lung cancer by sponging microRNA-328-5p |
External Links
| Links for LINC00210 | GenBank HGNC NONCODE |
| Links for non small cell lung cancer | OMIM COSMIC |